APA

Pearsall R. S., Davies M. V., Cannell M., Li J., Widrick J., Mulivor A. W., Wallner S., Troy M. E., Spaits M., Liharska K., Sako D., Castonguay R., Keates S., Grinberg A. V., Suragani R. N. V. S. & Kumar R. (20201027). Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease. : Scientific reports.

Chicago

Pearsall R S, Davies M V, Cannell M, Li J, Widrick J, Mulivor A W, Wallner S, Troy M E, Spaits M, Liharska K, Sako D, Castonguay R, Keates S, Grinberg A V, Suragani R N V S and Kumar R. 20201027. Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease. : Scientific reports.

Harvard

Pearsall R. S., Davies M. V., Cannell M., Li J., Widrick J., Mulivor A. W., Wallner S., Troy M. E., Spaits M., Liharska K., Sako D., Castonguay R., Keates S., Grinberg A. V., Suragani R. N. V. S. and Kumar R. (20201027). Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease. : Scientific reports.

MLA

Pearsall R S, Davies M V, Cannell M, Li J, Widrick J, Mulivor A W, Wallner S, Troy M E, Spaits M, Liharska K, Sako D, Castonguay R, Keates S, Grinberg A V, Suragani R N V S and Kumar R. Follistatin-based ligand trap ACE-083 induces localized hypertrophy of skeletal muscle with functional improvement in models of neuromuscular disease. : Scientific reports. 20201027.